Steve Boudewijns
Roosendaal, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
SusTained Employability in cancer Patients and their partnerS: Results of a Randomized Controlled Trial into the Effectiveness of the STEPS Program.
Journal: Journal of occupational rehabilitation
Published: March 05, 2026
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View.
Journal: European urology open science
Published: March 16, 2025
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients.
Journal: Oncoimmunology
Published: December 16, 2022
Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting.
Journal: European urology open science
Published: November 23, 2022
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination.
Journal: Oncoimmunology
Published: January 18, 2021
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Journal: Cancer immunology, immunotherapy : CII
Published: July 12, 2019
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 21, 2018
Dendritic cell vaccination in melanoma patients: From promising results to future perspectives.
Journal: Human vaccines & immunotherapeutics
Published: June 21, 2016
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Journal: Ophthalmology
Published: June 01, 2016
Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 27, 2016
Last Updated: 09/26/2026